J. Tierce's Profile

Role	Title	Level	Year	L/R
🐜	Predictors of adherence with antihypertensive and lipid-lowering therapy. 7 auth. R. Chapman, J. Benner, A. Petrilla, J. Tierce, S. Collins, D. Battleman, ... J. Schwartz	9	2005	9 🐜
🐜	Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study 8 auth. J. Munakata, E. Hazard, D. Serrano, D. Klingman, M. Rupnow, J. Tierce, ... M. Reed, R. Lipton	8	2009	8 🐜
🐜	Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers 13 auth. James Heyward, Christopher M. Jones, W. Compton, D. Lin, J. Losby, I. Murimi, G. Baldwin, Jeromie Ballreich, David A. Thomas, Mark C. Bicket, ... L. Porter, J. Tierce, G. Alexander	6	2018	6 🐜
🐬	Evidence‐based interventions to improve patient compliance with antihypertensive and lipid‐lowering medications A. Petrilla, J. Benner, D. Battleman, J. Tierce, E. Hazard	6	2005	6 🐬
🐜	Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy 8 auth. J. Benner, J. Tierce, C. Ballantyne, Cheryl Prasad, M. Bullano, V. Willey, ... J. Erbey, D. S. Sugano	6	2012	6 🐜
🐬	Costs of HIV+/AIDS at CD4+ counts disease stages based on treatment protocols. C. Gable, J. Tierce, D. Simison, D. Ward, Katy Motte	6	1996	6 🐬
🐜	Economic value of vaccines to address the COVID-19 pandemic: a U.S. cost-effectiveness and budget impact analysis 8 auth. W. Padula, S. Malaviya, N. Reid, Benjamin G Cohen, F. Chingcuanco, Jeromie Ballreich, ... J. Tierce, G. Alexander	5	2021	5 🐜
🐜	Healthcare Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States 11 auth. Irene B Murimi-Worstell, D. H. Lin, H. Kan, J. Tierce, Xia Wang, H. Nab, ... B. Desta, G. C. Alexander, Edward R. Hammond, G. C. CPhil, MD MS Alexander	5	2020	5 🐜
🐢	Clinical and Economic Outcomes of Nonadherence to Highly Active Antiretroviral Therapy in Patients With Human Immunodeficiency Virus J. Munakata, J. Benner, S. Becker, C. Dezii, E. Hazard, J. Tierce	5	2006	5 🐢
🐜	Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers 13 auth. Dora H. Lin, Christopher M. Jones, W. Compton, James Heyward, J. Losby, I. Murimi, G. Baldwin, Jeromie Ballreich, David A. Thomas, Mark C. Bicket, ... L. Porter, J. Tierce, G. Alexander	5	2018	5 🐜